[Methicillin-resistant Staphylococcus colonization. Impact on morbidity, mortality, and glycopeptide use].
Garrouste-Orgeas
F
F
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D003428:Cross Infection / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D005260:Female; D006020:Glycopeptides; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D016106:Methicillin Resistance; D009017:Morbidity; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D013211:Staphylococcus aureus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D006020:Glycopeptides